Markets:

Overview

News

Currencies

International

Treasuries

Connect Biopharma Holdings Limited - Ordinary Shares (NQ:CNTB)

2.334 -0.026 (-1.12%)

Streaming Delayed Price Updated: 1:24 PM EDT, May 22, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Connect Biopharma Holdings Limited - Ordinary Shares

< Previous 1 2 3 4 5 Next >

Connect Biopharma Touts Rademikibart’s Edge as SEABREEZE Data Looms in 2026 ↗

Today 0:05 EDT

Connect Biopharma (NASDAQ:CNTB) Chief Executive Officer Barry Quart said the company’s rademikibart program continues to show a differentiated clinical and mechanistic profile as the company awaits...

Via MarketBeat

Wondering what's happening in today's after-hours session? ↗

April 01, 2026

Via Chartmill

Which stocks have an unusual volume on Friday? ↗

November 21, 2025

Which stocks have an unusual volume on Friday?

Via Chartmill

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

November 19, 2025

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

October 02, 2025

Via Benzinga

Which stocks are moving before the opening bell on Wednesday? ↗

September 03, 2025

Wondering what's happening in Wednesday's pre-market session? Find an overview in this article.

Via Chartmill

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

September 03, 2025

Via Benzinga

Connect Biopharma Posts Q2 Revenue Drop ↗

August 13, 2025

Via The Motley Fool

Topics Intellectual Property

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

July 22, 2025

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

July 11, 2025

Via Benzinga

Tuesday's after hours session: top gainers and losers ↗

April 15, 2025

Discover the top movers in Tuesday's after-hours session and stay informed about the post-market dynamics.

Via Chartmill

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

April 07, 2025

Via Benzinga

Week In Review: EpimAb Sells T-Cell Engager In $635 Million Deal ↗

September 07, 2024

EpimAb Biotherapeutics sold global rights for a clinical-stage asset to Vignette Bio, a San Francisco startup, in a $635 million deal. Meanwhile, Shenzhen TargetRx raised $20 million by selling China...

Via Talk Markets

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

June 13, 2024

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

April 03, 2024

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

February 20, 2024

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

February 02, 2024

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

January 23, 2024

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

December 29, 2023

Via Benzinga

Week in Review: SystImmune Out-Licenses Global Rights for ADC to BMS in $8.4 Billion Deal ↗

December 16, 2023

SystImmune, the Seattle arm of Chengdu’s Biokin Pharma, out-licensed global rights (ex-China) for a bispecific ADC to Bristol Myers Squibb in a $8.4 billion agreement.

Via Talk Markets

Why Icosavax Shares Are Trading Higher By Around 45%; Here Are 20 Stocks Moving Premarket ↗

December 12, 2023

Shares of Icosavax, Inc. (NASDAQ: ICVX) rose sharply in pre-market trading after AstraZeneca announced plans to buy Icosavax in a deal valued at up to $1.1 billion.

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗

December 12, 2023

Checking out the biggest pre-market stock movers for Tuesday is the perfect way to get ready for another busy day of trading!

Via InvestorPlace

12 Health Care Stocks Moving In Monday's After-Market Session ↗

December 11, 2023

Via Benzinga

Week In Review: BeiGene Signs $1.3 Billion Deal For Preclinical CDK2 Inhibitor From Boston’s Ensem ↗

November 25, 2023

Beijing’s BeiGene acquired global rights to a preclinical novel cyclin-dependent kinase 2 (CDK2) inhibitor from Boston’s Ensem Therapeutics in a $1.3 billion agreement. Ensem will receive an upfront...

Via Talk Markets

Why Urban Outfitters Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

November 22, 2023

Shares of Urban Outfitters, Inc. (NASDAQ: URBN) dipped during Wednesday’s session after the company reported third-quarter financial results.

Via Benzinga

Why Guess? Shares Are Trading Lower By Around 15%; Here Are 20 Stocks Moving Premarket ↗

November 22, 2023

Shares of Guess?, Inc. (NYSE: GES) shares dipped in pre-market trading after the company reported worse-than-expected third-quarter financial results and issued fourth-quarter adjusted EPS guidance...

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

November 22, 2023

Pre-market stock movers are a hot topic on Wednesday as we check out all of the biggest movements happening this morning!

Via InvestorPlace

Why Is Skin Disease-Focused Connect Biopharma Stock Lower Today? ↗

November 21, 2023

Connect Biopharma Holdings Limited (NASDAQ: CNTB) released topline results from Stage 2 (maintenance period) of its China pivotal trial evaluating rademikibart's (formerly known as CBP-201) efficacy...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

November 21, 2023

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

November 21, 2023

Via Benzinga

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.